Pax6 is a Human Neuroectoderm Cell Fate Determinant.

Xiaoqing Zhang,Cindy T. Huang,Jing Chen,Matthew T. Pankratz,Jiajie Xi,Jin Li,Ying Yang,Timothy M. LaVaute,Xue-Jun Li,Melvin Ayala,Gennadiy I. Bondarenko,Zhong-Wei Du,Ying Jin,Thaddeus G. Golos,Su-Chun Zhang
DOI: https://doi.org/10.1016/j.stem.2010.04.017
IF: 23.9
2010-01-01
Cell Stem Cell
Abstract:The transcriptional regulation of neuroectoderm (NE) specification is unknown. Here we show that Pax6 is uniformly expressed in early NE cells of human fetuses and those differentiated from human embryonic stem cells (hESCs). This is in contrast to the later expression of Pax6 in restricted mouse brain regions. Knockdown of Pax6 blocks NE specification from hESCs. Overexpression of either Pax6a or Pax6b, but not Pax6triangle upPD, triggers hESC differentiation. However, only Pax6a converts hESCs to NE. In contrast, neither loss nor gain of function of Pax6 affects mouse NE specification. Both Pax6a and Pax6b bind to pluripotent gene promoters but only Pax6a binds to NE genes during human NE specification. These findings indicate that Pax6 is a transcriptional determinant of the human NE and suggest that Pax6a and Pax6b coordinate with each other in determining the transition from pluripotency to the NE fate in human by differentially targeting pluripotent and NE genes.
What problem does this paper attempt to address?